Introduction Polycystic ovary syndrome (PCOS) is a common hormonal, metabolic, and
reproductive disorder with a heterogeneous phenotype. As the exact etiology of PCOS is still …

Ovarian cancer is one of the most common gynecologic malignancies. It is characterized by
a high mortality rate, which is mainly due to the asymptomatic course of the disease. In light …

Background: Millions of women worldwide use exogenous hormones as oral contraceptives
or hormone replacement therapy. Still, time-dependent and long-term consequences of …

Epithelial ovarian cancer (EOC) represents a heterogeneous spectrum of disease entities at
a clinical, pathological and molecular level. Ovarian cancer is the second most lethal …

Background Evidence on a possible association between newer hormonal contraceptives
(HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen …

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged
women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian …

Background Oral contraceptive use has been associated with a higher breast cancer risk;
however, evidence for the associations between different oral contraceptive formulations …

Context The causal role of endogenous estradiol in cancers other than breast and
endometrial cancer remains unclear. Objective This Mendelian randomization study …

Background High levels of estrogen are associated with increased risk of breast and
endometrial cancer and have been suggested to also play a role in the development of …

Background The associations of oral contraceptive (OC) use with cardiovascular disease
(CVD) and all‐cause death remains unclear. We aimed to determine the associations of OC …